Skip to main content
Equibles

Ensign Peak Advisors, Inc

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1454984 SALT LAKE CITY, UT
Back to AGIO Full portfolio

Position in AGIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,045,049
+$10,822,786 QoQ
Shares Held
297,630
+4430.1% QoQ
Ownership
0.499%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#44
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ensign Peak Advisors, Inc holds $1,119,129,230 across 124 Biotechnology names. AGIO ranks #30 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 210,483 $104,553,220
2 INSM
INSMED Inc
 702,951 $74,948,635
3 ABVX
Abivax S.A.
 504,471 $67,225,805
4 BBIO
BridgeBio Pharma, Inc.
 760,977 $56,677,566
5 ARGX
Argenx SE
 52,027 $48,269,089
6 PTCT
Ptc Therapeutics, Inc.
 508,056 $41,442,127
7 TVTX
Travere Therapeutics, Inc.
 591,815 $33,621,010
8 SRRK
Scholar Rock Holding Corp
 579,052 $31,847,860

All Filings in AGIO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,045,049 297,630
2026-03-31 $222,263 6,570
2025-12-31 $178,835 6,570
2025-09-30 $506,566 12,620
2025-06-30 $830,502 24,970
2025-03-31 $935,256 31,920
2024-12-31 $1,048,891 31,920
2024-09-30 $1,418,205 31,920
2024-06-30 $1,376,390 31,920
2024-03-31 $933,340 31,920
2023-12-31 $746,713 33,530
2023-09-30 $829,867 33,530
2023-06-30 $949,569 33,530
2023-03-31 $770,184 33,530
2022-12-31 $941,522 33,530
2022-09-30 $351,520 12,430
2022-06-30 $270,030 12,180
2022-03-31 $354,559 12,180
2021-12-31 $400,356 12,180